- Joined
- Dec 17, 2007
- Messages
- 3,364
- Reaction score
- 4,354
Interesting article pointing out, that you cannot tailor the indication to adjuvant post-lumpectomy radiation therapy by molecular testing:
http://www.ncbi.nlm.nih.gov/pubmed/25867274
I am curious to see how this story goes... Oncotype Dx has shaken up alot the adjuvant chemo setting for the med. oncologists. The same company is also providing a test for DCIS.
http://www.ncbi.nlm.nih.gov/pubmed/25867274
I am curious to see how this story goes... Oncotype Dx has shaken up alot the adjuvant chemo setting for the med. oncologists. The same company is also providing a test for DCIS.